Best for
Mobile

Chembio Diagnostics, Inc (CEMI) is a leading diagnostics and research business based in the US. It opened the day at $4.75 after a previous close of $4.7. During the day the price has varied from a low of $4.67 to a high of $4.85. The latest price was $4.82 (25 minute delay). Chembio Diagnostics is listed on the NASDAQ and employs 355 staff. All prices are listed in US Dollars.
Open | $4.75 |
---|---|
High | $4.85 |
Low | $4.67 |
Close | $4.82 |
Previous close | $4.7 |
Change | $0.12 |
Change % | 2.5532% |
Volume | 217,958 |
52-week range | $3.01 - $15.89 |
---|---|
50-day moving average | $4.4583 |
200-day moving average | $5.2888 |
Wall St. target price | $9 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.73 |
Other fees may apply. Your capital is at risk.
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
---|---|---|---|---|
![]() |
£0 | No minimum | £6.30 £351.27 total |
Capital at risk |
![]() |
£0 | $200 | £1.72 £346.69 total |
Capital at risk |
![]() |
£0 | £0.01 | £1.06 £346.03 total |
Capital at risk |
![]() |
£0 | £50 | £2.01 £346.98 total |
Capital at risk |
![]() |
£0 | £1 | £15.69 £360.65 total |
Capital at risk |
![]() |
£9.99 per month | No minimum | £13.45 £358.42 total |
Capital at risk |
![]() |
£36 per year | £20 | £14.10 £359.07 total |
Capital at risk |
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of $4.82
1 week (2021-04-09) | 17.85% |
---|---|
1 month (2021-03-19) | 15.31% |
3 months (2021-01-20) | -23.97% |
6 months (2020-10-20) | -1.83% |
1 year (2020-04-20) | -65.67% |
---|---|
2 years (2019-04-18) | -31.63% |
3 years (2018-04-20) | -38.99% |
5 years (2016-04-20) | -33.24% |
Revenue TTM | $32.5 million |
---|---|
Gross profit TTM | $-912,784 |
Return on assets TTM | -22.75% |
Return on equity TTM | -98.52% |
Profit margin | -78.6% |
Book value | $1.376 |
Market capitalisation | $78.2 million |
TTM: trailing 12 months
There are currently 2.0 million Chembio Diagnostics shares held short by investors – that's known as the "short interest". This figure is 0.1% down from 2.0 million last month.
There are a few different ways that this level of interest in shorting Chembio Diagnostics shares can be evaluated.
Chembio Diagnostics's "short interest ratio" (SIR) is the quantity of Chembio Diagnostics shares currently shorted divided by the average quantity of Chembio Diagnostics shares traded daily (recently around 800848.17813765). Chembio Diagnostics's SIR currently stands at 2.47. In other words for every 100,000 Chembio Diagnostics shares traded daily on the market, roughly 2470 shares are currently held short.
However Chembio Diagnostics's short interest can also be evaluated against the total number of Chembio Diagnostics shares, or, against the total number of tradable Chembio Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chembio Diagnostics's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Chembio Diagnostics shares in existence, roughly 100 shares are currently held short) or 0.0998% of the tradable shares (for every 100,000 tradable Chembio Diagnostics shares, roughly 100 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chembio Diagnostics.
Find out more about how you can short Chembio Diagnostics stock.
We're not expecting Chembio Diagnostics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Chembio Diagnostics's shares were split on a 1:8 basis on 29 May 2012. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Chembio Diagnostics shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Chembio Diagnostics shares which in turn could have impacted Chembio Diagnostics's share price.
Over the last 12 months, Chembio Diagnostics's shares have ranged in value from as little as $3.01 up to $15.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chembio Diagnostics's is 1.8312. This would suggest that Chembio Diagnostics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Subscribe to trending stock alerts for a chance to win
Everything we know about the Darktrace IPO, plus information on how to buy it.
Everything we know about the Wise IPO, plus information on how to buy it.
Everything we know about the PensionBee IPO, plus information on how to buy it.
Ever wondered how to buy shares in Sesen Bio? We explain how and compare a range of providers that can give you access to many brands, including Sesen Bio.
Ever wondered how to buy shares in Precipio? We explain how and compare a range of providers that can give you access to many brands, including Precipio.
Ever wondered how to buy shares in NTT DOCOMO INC? We explain how and compare a range of providers that can give you access to many brands, including NTT DOCOMO INC.
Ever wondered how to buy shares in Impinj? We explain how and compare a range of providers that can give you access to many brands, including Impinj.
Ever wondered how to buy shares in Homology Medicines? We explain how and compare a range of providers that can give you access to many brands, including Homology Medicines.
Ever wondered how to buy shares in H&E Equipment Services? We explain how and compare a range of providers that can give you access to many brands, including H&E Equipment Services.
Ever wondered how to buy shares in GTT Communications? We explain how and compare a range of providers that can give you access to many brands, including GTT Communications.